We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
12 April 2023
Intel Capital, a leading investor in the future of compute, has invested in UNISERS AG, a Swiss semiconductor metrology company that identifies invisible contamination-caused defects in semiconductor materials. The USD14m seed financing round was led by Intel Capital, with participation from M Ventures, RSBG Ventures and Swisscom Ventures. The funding will enable UNISERS to accelerate the delivery of its commercial products to leading semiconductor partners by 2023. In addition, the company will be able to demonstrate the value of the technology in a number of further critical use cases.
VISCHER AG advised Intel Capital with a team lead by Matthias Staehelin with Vincent Reardon, Luzius Zumstein and Melissa Briatico (all Corporate/M&A).
Categories: Corporate and Commercial, Information and Communication Technology, Private Equity & Venture Capital, Startup Desk
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law
Luciole Medical, a Swiss medical technology company specialized in brain monitoring, acquires...
Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company purposefully driven to save...
VISCHER advised Mosanna Therapeutics AG in closing an extension of the Seed Financing Round with...